Apolipoprotein A-I and paraoxonase-1 are potential blood biomarkers for ischemic stroke diagnosis

Kyle B. Walsh, Kimberly Hart, Susan Roll, Matthew Sperling, Dusten Unruh, W. Sean Davidson, Christopher J. Lindsell, Opeolu Adeoye

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


Background Blood biomarkers for ischemic and hemorrhagic stroke diagnosis remain elusive. Recent investigations suggested that apolipoprotein (Apo), matrix metalloproteinase (MMP), and paraoxonase-1 may be associated with stroke. We hypothesized that Apo A-I, Apo C-I, Apo C-III, MMP-3, MMP-9, and paraoxonase-1 are differentially expressed in ischemic stroke, hemorrhagic stroke, and controls. Methods In a single-center prospective observational study, consecutive stroke cases were enrolled if blood samples were obtainable within 12 hours of symptom onset. Age- (±5 years), race-, and sex-matched controls were recruited. Multiplex assays were used to measure protein levels. The Wilcoxon signed-rank test and the Mann-Whitney U-test were used to compare biomarker values between ischemic stroke patients and controls, hemorrhagic stroke patients and controls, and ischemic and hemorrhagic stroke patients. The 95% confidence intervals (CIs) for the difference of 2 medians were calculated. Results Fourteen ischemic stroke case-control pairs and 23 intracerebral hemorrhage (ICH) case-control pairs were enrolled. Median Apo A-I levels were lower in ischemic stroke cases versus controls (140 mg/dL versus 175 mg/dL, difference of 35 mg/dL, 95% CI -54 to -16) and in ischemic stroke versus ICH cases (140 mg/dL versus 180 mg/dL, difference of 40 mg/dL, 95% CI -57 to -23). Median paraoxonase-1 was lower in ischemic stroke cases than in both ICH cases and matched controls. Median Apo C-I was slightly lower in ischemic stroke cases than in ICH cases. There were no differences between groups for MMP-3, MMP-9, and Apo C-III. Conclusion Apo A-I and paraoxonase-1 levels may be clinically useful for ischemic stroke diagnosis and for differentiating between ischemic and hemorrhagic strokes.

Original languageEnglish
Pages (from-to)1360-1365
Number of pages6
JournalJournal of Stroke and Cerebrovascular Diseases
Issue number6
StatePublished - Jun 1 2016


  • Ischemic stroke
  • biomarker
  • diagnosis
  • intracerebral hemorrhage
  • plasma
  • proteomics


Dive into the research topics of 'Apolipoprotein A-I and paraoxonase-1 are potential blood biomarkers for ischemic stroke diagnosis'. Together they form a unique fingerprint.

Cite this